Interview with Professor Jack Heinemann, Director of the Centre for Integrated Research in Biosafety (INBI), Tessa Hiscox and Andrew McCabe. Based at the Centre for Integrated Research in Biosafety (INBI), at New Zealand's University of Canterbury, & some of the co-authors of INBI's Submission to the Parliament Health Committee on the Gene Technology Bill 2024.
Authors: Jack A. Heinemann (PhD), Brigitta Kurenbach (PhD), Tessa C. Hiscox (BHons), Andrew W. McCabe (MSc), and Sophie Walker (PhD) Corresponding author: Jack Heinemann (jack.heinemann@canterbury.ac.nz), 03 336 95597.
(Prepared in accordance with the Critic and Conscience of Society and Academic Freedom Policy (2024). This may not be the opinion of the University of Canterbury.)
Submission PDF available via Professor Jack Heinemann's research profile.
Also accessible via our Physicians & Scientists for Global Responsibility New Zealand (PSGR) website.
For an audio version of this interview: PSGRNZ.Substack.com
Submissions to the Gene Technology Bill can be made by Feb, 17, 2025.
Share this post